Sublime Canna: Building the Next Big Cannabis Brands
May 23rd, 2019
App, Exclusive, News, Top Story
California’s cannabis industry is expected to reach $5.1 billion in 2019, according to Arcview and BDS Analytics, driven by the legalization of adult-use cannabis last year. With nearly 40 million residents and more than a million medical marijuana patients, the state’s market represents about a third of the North American cannabis industry. Cannabis edibles and concentrates have surpassed cannabis flower as the most popular product format.
Sublime Canna, an award-winning cannabis manufacturing company located in Oakland, is well positioned to capitalize on these trends. Let’s take a look at what sets Sublime Canna apart from the competition and where the company is headed over the coming quarters.
Unrelenting Focus on Quality
Many cannabis companies are focusing on scaling up their production capacity at any cost. While these companies may generate the greatest early revenue, the lack of product quality eventually catches up to brand reputation and hurts profit margins. Investors may want to shift their focus to cannabis companies that have a strong understanding of cannabis cultivation, manufacturing processes, and other elements of quality control.
Sublime Canna addresses these issues by taking control over the entire cannabis production process. Starting with pesticide-free buds from partners, the company manufactures cannabis oils and concentrates using state of the art cold ethanol extraction machines designed to maintain the plant’s natural profile. The company’s team then reintroduces full-spectrum terpenes to the oil for enhanced flavor and effect.
The company’s pre-rolls and edibles use similar quality control systems. Pre-rolls are made from the finest premium flower and are sprinkled with extract and rolled in oil and kief, and edibles utilize industry-leading confectionery manufacturing to produce the best tasting edibles on the market with precise dosages. Throughout all of these processes, the company aims to bring a high level of science to the cannabis production process.
Unique Products & Distribution
Sublime is well-known for its vaporizer cartridges and Fuzzies pre-rolls, which are already widely distributed throughout California and have received several awards. Most recently, the company’s CBD-infused Sleep and High-C vape cartridges were awarded both first and second place at the 2018 Emerald Cup for “Best CBD Concentrate.” The company’s Sublime Gold cartridges are its flagship line with terpene blends that provide a “dab-like” pull.
In February, the company launched its first edible product, Dosies, a cannabis-infused, low-dose mint. With the tagline, “A Tiny Miracle in Every Mint”, Dosies provide a smooth and sweet shell for a delicious and different experience. With 2mg of THC per mint, they provide consistent microdosing for individual consumers and a product format that’s both portable and discreet for anyone seeking a unique experience.
“Expanding into the edibles space is an exciting move for Sublime,” said CEO Alex Fang in the press release announcing the new product launch into the multibillion dollar edibles space. “Customers already know and love our prized vapes and ‘Fuzzies’ prerolls. With the introduction of the world’s first ‘panned’ cannabis mint we are confident that Dosies will be just as beloved. I like to say it’s a microdose with a perfect coat.”
California’s cannabis industry is projected to top $5 billion this year and edibles and concentrates are the fastest growing segments. While many companies are rapidly scaling into the business, only a handful are creating premium brands that have staying power. Sublime Canna, an award-winning cannabis manufacturing company located in Oakland, is one of those quality brands that’s building a strong presence.
Last year, the company closed a $6.2 million Series A and plans on using the proceeds to expand production capacity and launch new products to meet the growing demand for high-quality legal cannabis products in California.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.